Cargando…
Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities
Nuclear factor E2-related factor 2 (NRF2) plays an important role in redox metabolism and antioxidant defense. Under normal conditions, NRF2 proteins are maintained at very low levels because of their ubiquitination and proteasomal degradation via binding to the kelch-like ECH associated protein 1 (...
Autores principales: | Jung, Byung-Jin, Yoo, Hwan-Sic, Shin, Sooyoung, Park, Young-Joon, Jeon, Sang-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746038/ https://www.ncbi.nlm.nih.gov/pubmed/29212307 http://dx.doi.org/10.4062/biomolther.2017.195 |
Ejemplares similares
-
The status of Nrf2-based therapeutics: current perspectives and future prospects
por: Gazaryan, Irina G., et al.
Publicado: (2016) -
HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities
por: Lindl, Kathryn A., et al.
Publicado: (2010) -
Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?
por: Bates, Jennifer, et al.
Publicado: (2014) -
The molecular understanding of super-enhancer dysregulation in cancer
por: Yoshino, Seiko, et al.
Publicado: (2022) -
Neuroprotective mechanisms and translational potential of therapeutic hypothermia in the treatment of ischemic stroke
por: Lee, Jin Hwan, et al.
Publicado: (2017)